Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech's application, seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
"After detailed deliberation, the committee recommended for conduct of proposed phase II/III clinical trial of whole virion inactivated coronavirus vaccine in the 2 to 18 years age group subject to the condition that the firm should submit the interim safety data of phase II clinical trial along with DSMB recommendations to the CDSCO before proceeding to phase III part of the study," a source said.
Earlier the proposal was deliberated in the SEC meeting dated February 24 and the firm was asked to submit a revised clinical trial protocol.
Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is being used in adults in India's ongoing COVID-19 vaccination drive.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
New XEC Covid Variant Spreads To 27 Countries, Here's What We Know So Far Study Shows How Long Covid Is Debilitating Children's Health Bharat Biotech Unveils Next-Gen Oral Cholera Vaccine To Address Global Health Gaps Election Results 2024 LIVE: With Thumping Win, Maharashtra Decides Real NCP, Sena Election Results: Mahayuti Takes Lead In 230 Maharashtra Seats Jharkhand Election Results LIVE: INDIA Bloc Wins 14 Seats, NDA Takes 2 Gangster Married In UP To Miss Own Wedding Reception Due To District Ban After UP Bypoll Sweep, Yogi Adityanath Doubles Down On 'Batenge Toh Katenge' G7 Ministers To Discuss ICC Warrant For Netanyahu Next Week: Italy PM Meloni Track Latest News Live on NDTV.com and get news updates from India and around the world.